Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03122912
Other study ID # HUM00113555 / Derm 683
Secondary ID
Status Terminated
Phase Phase 1
First received
Last updated
Start date January 24, 2018
Est. completion date February 1, 2021

Study information

Verified date April 2021
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to explore the potential differences in the skin of people who take fish oil versus soybean oil pills.


Recruitment information / eligibility

Status Terminated
Enrollment 17
Est. completion date February 1, 2021
Est. primary completion date February 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years to 99 Years
Eligibility Inclusion Criteria: - At least 50 years of age. - Good general health. - No disease states or physical conditions, which would impair evaluation of the biopsy sites. - Signed, written and witnessed, Informed Consent Form - BMI is between 18 to 36 kg/m2 Exclusion Criteria: - Pregnant or lactating women or women contemplating pregnancy for the duration of the protocol. A pregnant test will not be given to women who are capable to pregnant. - Lovaza™ (prescription fish oil) and not willing to go off Lovaza for 3 weeks prior to enrollment to end of study. - Frequent NSAID use (not including low dose aspirin) and not willing to go off NSAIDS for 3 weeks prior to enrollment and to end of study. - Steroids (except inhaled steroids for asthma) and not willing to go off steroids for 3 weeks prior to enrollment to end of study. - Other medications that may affect the biomarkers of interest. - Any supplement use (i.e. fish oils, flax seed oils and other oils) that can affect the biomarkers of interest. - Diet with frequent (1-2 days per week) oily fish (mackerel, salmon, sardines, cold water fish, et al). - History of photosensitive conditions (connective tissue diseases, polymorphous light eruption, porphyrias etc). - Received an experimental drug or used experimental device in the 30 days prior to admission to the study. - History of keloids or any other condition that would complicate wound healing. - Allergic to soybean, soybean oil, peanuts or seafood. - History of allergic reactions to local anesthetics.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Fish Oil
Capsules contain omega-3 fatty acids (fish oil). Dosage of 3180 mg of omega-3 fatty acids will be taken orally daily up to 16 weeks.
Soybean Oil
Dosage will be 3000 mg of soybean oil taken orally daily for up to 16 weeks.

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (1)

Lead Sponsor Collaborator
University of Michigan

Country where clinical trial is conducted

United States, 

References & Publications (11)

Black HS, Rhodes LE. Potential Benefits of Omega-3 Fatty Acids in Non-Melanoma Skin Cancer. J Clin Med. 2016 Feb 4;5(2). pii: E23. doi: 10.3390/jcm5020023. Review. — View Citation

Flock MR, Skulas-Ray AC, Harris WS, Gaugler TL, Fleming JA, Kris-Etherton PM. Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults. Prostaglandins Leukot Essent Fatty Acids. 2014 Oct;91(4):161-8. doi: 10.1016/j.plefa.2014.07.006. Epub 2014 Jul 17. — View Citation

Millsop JW, Bhatia BK, Debbaneh M, Koo J, Liao W. Diet and psoriasis, part III: role of nutritional supplements. J Am Acad Dermatol. 2014 Sep;71(3):561-9. doi: 10.1016/j.jaad.2014.03.016. Epub 2014 Apr 26. Review. — View Citation

Mozurkewich EL, Clinton CM, Chilimigras JL, Hamilton SE, Allbaugh LJ, Berman DR, Marcus SM, Romero VC, Treadwell MC, Keeton KL, Vahratian AM, Schrader RM, Ren J, Djuric Z. The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial. Am J Obstet Gynecol. 2013 Apr;208(4):313.e1-9. doi: 10.1016/j.ajog.2013.01.038. — View Citation

Pilkington SM, Rhodes LE, Al-Aasswad NM, Massey KA, Nicolaou A. Impact of EPA ingestion on COX- and LOX-mediated eicosanoid synthesis in skin with and without a pro-inflammatory UVR challenge--report of a randomised controlled study in humans. Mol Nutr Food Res. 2014 Mar;58(3):580-90. doi: 10.1002/mnfr.201300405. Epub 2013 Dec 5. — View Citation

Rhodes LE, Durham BH, Fraser WD, Friedmann PS. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J Invest Dermatol. 1995 Oct;105(4):532-5. — View Citation

Rhodes LE, O'Farrell S, Jackson MJ, Friedmann PS. Dietary fish-oil supplementation in humans reduces UVB-erythemal sensitivity but increases epidermal lipid peroxidation. J Invest Dermatol. 1994 Aug;103(2):151-4. — View Citation

Rhodes LE, Shahbakhti H, Azurdia RM, Moison RM, Steenwinkel MJ, Homburg MI, Dean MP, McArdle F, Beijersbergen van Henegouwen GM, Epe B, Vink AA. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers. Carcinogenesis. 2003 May;24(5):919-25. — View Citation

Shinto L, Marracci G, Mohr DC, Bumgarner L, Murchison C, Senders A, Bourdette D. Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study. PLoS One. 2016 Jan 22;11(1):e0147195. doi: 10.1371/journal.pone.0147195. eCollection 2016. — View Citation

Tecklenburg-Lund S, Mickleborough TD, Turner LA, Fly AD, Stager JM, Montgomery GS. Randomized controlled trial of fish oil and montelukast and their combination on airway inflammation and hyperpnea-induced bronchoconstriction. PLoS One. 2010 Oct 18;5(10):e13487. doi: 10.1371/journal.pone.0013487. — View Citation

Vargas ML, Almario RU, Buchan W, Kim K, Karakas SE. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism. 2011 Dec;60(12):1711-8. doi: 10.1016/j.metabol.2011.04.007. Epub 2011 Jun 2. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Change in barrier function improvement from Baseline to Week 16. Barrier function will be measured at baseline and 16 weeks. Differences in barrier function between the two visits will be assessed. 16 weeks
Primary Number of subjects with barrier function improvement from Baseline to Week 16. Barrier function will be measured at baseline and 16 weeks. The number of subjects with dichotomized improvement in barrier function between the two visits will be compared. 16 weeks
Secondary Change in Omega-3 Fatty Acid Levels in blood from Baseline to Week 16. Omega-3 fatty acids in blood will be measured at baseline and 16 weeks. Differences in levels between the two visits will be assessed. 16 weeks
Secondary Number of subjects with increased Omega-3 Fatty Acid Levels in Blood from Baseline to Week 16. Omega-3 fatty acids in blood will be measured at baseline and 16 weeks. The number of subjects with dichotomized improvement in levels between the two visits will be compared. 16 weeks
See also
  Status Clinical Trial Phase
Completed NCT05098912 - Comparing Polydioxanone Thread Embedding Acupuncture and Manual Acupuncture for Nasolabial Fold Reduction N/A
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT04061785 - Impact of Skills Acquired Through Judo Training on Risk Factors for Falling in Elderly Men and Women N/A
Active, not recruiting NCT05961319 - Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
Recruiting NCT04518423 - Prevalence, Determinants and Natural History of Frailty and Pre-frailty in Elderly People
Not yet recruiting NCT06434857 - Effectiveness of a Strength Program Over Cognitive Functionality in Older Adults N/A
Active, not recruiting NCT03371238 - Effect of Floorball on Healthy Subjects N/A
Recruiting NCT05651854 - Effect of Different Pranayama Breathing Techniques on Quality of Life in Hypertensive Patients N/A
Recruiting NCT04982497 - Development and Evaluation of a Psychological Intervention in Videogame Format for the Promotion of Active Aging N/A
Enrolling by invitation NCT03299374 - Effectiveness of the Pilates Method to Prevent and Reduce Falls in Older People N/A
Not yet recruiting NCT06000605 - Brain Substrate Switch to Ketones and Lactate N/A
Recruiting NCT05756140 - Efficiency of Facial Expression Diagnostic System in Pain Assessment After Geriatric Surgery
Completed NCT04563663 - Dose-response of Anteroposterior Mobilizations in Weight Bearing Talus Dorsiflexion N/A
Active, not recruiting NCT06448052 - Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation Phase 1/Phase 2
Completed NCT03643237 - Gaming Applied to the Promotion of Active Aging N/A
Completed NCT03323008 - E-training of Inmate Peer Caregivers for Enhancing Geriatric and End-of-life Care in Prisons N/A
Terminated NCT04360512 - Dose-response of Talus Mobilizations N/A
Completed NCT05015777 - Effects of Jaques-Dalcroze Eurhythmics Program on Postural Stability in Elderly Women. N/A
Completed NCT05284292 - GUARDIAN: The Social Robot Companion to Support Homecare Nurses N/A
Recruiting NCT05419609 - Comparison of an Office-based Limited Facelift and Hospital-based Full Facelift N/A